Sleep Duration Linked to Diabetes Risk in Multiple Long-Term Studies

Recent research findings from multiple cohort studies indicate that sleep duration is linked to the risk of developing type 2 diabetes and insulin resistance. These studies provide evidence that both insufficient and excessive nightly sleep may be associated with less favorable metabolic outcomes.

Observational analyses have identified a U-shaped relationship between sleep duration and diabetes risk, with both shorter and longer sleep linked to higher risk compared to moderate sleep durations. Data from the EGIR-RISC study, which included participants from several European centers, found that individuals with either short or long sleep durations had lower insulin sensitivity, a factor associated with insulin resistance.

Further evidence from a 7-year longitudinal study in China showed that, within a nightly sleep range of 3.5 to 7.5 hours, each additional hour of sleep was linked to a 15% reduction in diabetes risk. However, the study reported that sleeping more than 7.5 hours per night did not provide additional benefit regarding diabetes risk.

Long-term follow-up research from Korea tracked participants for 16 years and found that those sleeping five hours or less per night experienced a higher incidence of type 2 diabetes than those sleeping more than five but less than seven hours. Another 14-year study reported that sleeping 10 hours or more per day was associated with increased diabetes risk, while the lowest risk was observed among those sleeping eight to nine hours per night.

What the numbers show

• Each extra hour of sleep between 3.5 and 7.5 hours reduced diabetes risk by 15% in a Chinese cohort
• Sleeping ≤5 hours per night was linked to higher diabetes incidence over 16 years in a Korean study
• Lowest diabetes risk was found among those sleeping 8–9 hours, while ≥10 hours increased risk in a 14-year study

The EGIR-RISC study used regression analyses to further examine the relationship between sleep and metabolic health. The findings indicated that both short and long sleep durations were associated with reduced insulin sensitivity, reinforcing the link between sleep patterns and risk factors for diabetes.

Synthesized results from multiple cohort studies suggest that approximately seven hours of nightly sleep is associated with more favorable metabolic health. Both insufficient and excessive sleep durations have been linked to impaired insulin sensitivity, which is a key factor in the development of type 2 diabetes.

These findings highlight the importance of considering sleep habits as part of broader efforts to understand and address metabolic health risks. The consistent association between sleep duration and diabetes risk across diverse populations and study designs supports ongoing research into optimal sleep patterns for health.

While the studies reviewed focused on observational data, they collectively indicate that maintaining a moderate sleep duration may be beneficial for reducing the risk of type 2 diabetes. Further research may help clarify the mechanisms underlying these associations and inform public health recommendations.

* This article is based on publicly available information at the time of writing.